Td. Giugni et al., NEUTRALIZATION OF HUMAN CYTOMEGALOVIRUS BY HUMAN CD13-SPECIFIC ANTIBODIES, The Journal of infectious diseases, 173(5), 1996, pp. 1062-1071
The mechanisms of inhibition of cytomegalovirus (CMV) infection by hum
an CD13 (aminopeptidase N)-specific antibodies were studied, These ant
ibodies protect CD13-negative and -positive cells from CMV infection o
nly if incubated with the virus inoculum, suggesting they bind to CMV
virions, The association of a CD13-like molecule with virions was furt
her supported by the transfer of CD13 immunoreactivity to the surface
of CD13-negative cells upon binding of CMV; the binding of CD13-specif
ic antibodies directly to the surface of CMV virions; and the presence
of anti-CD13 immunoreactive bands, including one with mobility simila
r to that of native cellular CD13 on immunoblots of proteins of purifi
ed CMV particles, Importantly, CD13-specific antibodies neutralize CMV
in urine of neonates with congenital CMV, indicating that the CD13-li
ke molecule is associated with natural CMV and not acquired in vitro,
These studies demonstrate that a CD13-like molecule is associated with
CMV particles and may be important in CMV pathogenesis.